378 results
Strategic Decisions in Early R&D for Antibody Research & Discovery: A Forward-Looking Perspective
Proteins, Antibodies & ADCs

Strategic Decisions in Early R&D for Antibody Research & Discovery: A Forward-Looking Perspective

News
Oct , 2025
Clinical Challenges in the Application of Cell Engagers: Current Hurdles and Future Horizons
Proteins, Antibodies & ADCs

Clinical Challenges in the Application of Cell Engagers: Current Hurdles and Future Horizons

News
Oct , 2025
mRNA Allergy Vaccine ‘A Potential Breakthrough for Millions’, says Nobel Laureate
Vaccines

mRNA Allergy Vaccine ‘A Potential Breakthrough for Millions’, says Nobel Laureate

News
Oct , 2025
Building Quality by Design for Antibody Based Therapeutics
Proteins, Antibodies & ADCs

Building Quality by Design for Antibody Based Therapeutics

Technology Spotlight
Oct , 2025
Adding a Decade to the Healthy Human Lifespan: Interview with Joe Betts-LaCroix, Retro Bio

Adding a Decade to the Healthy Human Lifespan: Interview with Joe Betts-LaCroix, Retro Bio

Thought Leadership
Oct , 2025
Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration
Proteins, Antibodies & ADCs

Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration

News
Sep , 2025
A Regenerative Cell Therapy for Blindness: Interview with Kristian Tryggvason, Alder Therapeutics
Cell & Gene

A Regenerative Cell Therapy for Blindness: Interview with Kristian Tryggvason, Alder Therapeutics

Thought Leadership
Sep , 2025
Analysis of Neuropeptide Function Using New Tool
Peptides

Analysis of Neuropeptide Function Using New Tool

News
Sep , 2025
Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration
Proteins, Antibodies & ADCs

Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration

Thought Leadership
Sep , 2025
“Dawn of a new age”: RNA Silencing Therapy Slows Huntington’s Disease by 75% in Clinical Trial
Cell & Gene

“Dawn of a new age”: RNA Silencing Therapy Slows Huntington’s Disease by 75% in Clinical Trial

News
Sep , 2025
Putting our Brains in Drug Discovery: Interview with Joshua Bagley, A:head Bio
Cell & Gene

Putting our Brains in Drug Discovery: Interview with Joshua Bagley, A:head Bio

Thought Leadership
Sep , 2025
Platform Development for the Purification of rAAV Vectors: Interview with Jessica Whelan, University College Dublin
Cell & Gene Vaccines

Platform Development for the Purification of rAAV Vectors: Interview with Jessica Whelan, University College Dublin

Thought Leadership
Sep , 2025
Exploring Novel 3D Bioprinting Technologies: Interview with Kenny Dalgarno, University of Newcastle
Proteins, Antibodies & ADCs

Exploring Novel 3D Bioprinting Technologies: Interview with Kenny Dalgarno, University of Newcastle

Thought Leadership
Sep , 2025
Topical Gene Therapy for Rare Skin Disease Gets Expanded Label
Cell & Gene

Topical Gene Therapy for Rare Skin Disease Gets Expanded Label

News
Sep , 2025
Towards Context Aware Cell Line Development: Interview with Duygu Dikicioglu, UCL
Cell & Gene

Towards Context Aware Cell Line Development: Interview with Duygu Dikicioglu, UCL

Thought Leadership
Sep , 2025
Scaling up Complex Organoid Models: Interview with Maryna Panamarova, Wellcome Sanger Institute
Cell & Gene

Scaling up Complex Organoid Models: Interview with Maryna Panamarova, Wellcome Sanger Institute

Thought Leadership
Sep , 2025
Promising Reports from First-in-Human Trial for ADC SCLC
Proteins, Antibodies & ADCs

Promising Reports from First-in-Human Trial for ADC SCLC

News
Sep , 2025
Report Details Bispecific Antibody Drug Conjugate Market Ripe with Key Partnerships
Proteins, Antibodies & ADCs

Report Details Bispecific Antibody Drug Conjugate Market Ripe with Key Partnerships

News
Sep , 2025
Clonogenic Hepatocytes are Important Targets for Paediatric Gene Therapies, say Researchers
Cell & Gene

Clonogenic Hepatocytes are Important Targets for Paediatric Gene Therapies, say Researchers

News
Sep , 2025
Double Strike for Akeso’s mAbs in Phase III Treating Atopic Dermatitis & Ankylosing Spondylitis
Proteins, Antibodies & ADCs

Double Strike for Akeso’s mAbs in Phase III Treating Atopic Dermatitis & Ankylosing Spondylitis

News
Sep , 2025
Natural Enzyme ‘Staples’ Peptides into Macrocycles, Expanding Therapeutic Potential

Natural Enzyme ‘Staples’ Peptides into Macrocycles, Expanding Therapeutic Potential

News
Sep , 2025

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.